Pancreatic Cancer Research

ResearcherDuke UniversityActive in the last 2 years

Christopher M Counter

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0748-3079; OpenAlex author ID A5087099776; NIH RePORTER profile ID 6388871. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
4
Labs led
1
Collaborators
30
Papers, trials and grants by year

2011: 1 grant · 2012: 1 paper, 1 grant · 2013: 1 grant · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 grant · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-25-2630↗
  2. CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment. Co-author DOI 10.1016/j.celrep.2021.110060↗
  3. Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer. Last author DOI 10.1371/journal.pone.0140253↗
  4. Targeting eNOS in pancreatic cancer. Last author DOI 10.1158/0008-5472.can-12-0057↗

Grants 4

  1. Dynamic requirements of Ras signaling during cancer R01CA123031↗
  2. Evaluating the impact of KRas codon bias on pancreatic cancer R03CA165927↗
  3. Small molecular weight eNOS inhibitors for the treatment of pancreatic cancer R21CA153240↗
  4. Molecular Mechanisms of Neoplastic Transformation in Human Cells R01CA094184↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Channing J. Der · 2 shared papers, 2021–2026 · strength 0.30
  2. David F. Kashatus · 2 shared papers, 2012–2026 · strength 0.24
  3. Lu Han · 1 shared paper, 2026 · strength 0.21
  4. Christabelle Rajesh · 1 shared paper, 2026 · strength 0.21
  5. Rachel A. Burge · 1 shared paper, 2026 · strength 0.21
  6. Victoria K. Spadafora · 1 shared paper, 2026 · strength 0.21
  7. Denis C. Guttridge D · 1 shared paper, 2026 · strength 0.21
  8. Thomas B. McFall · 1 shared paper, 2026 · strength 0.21
  9. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.21
  10. Todd W. Bauer · 1 shared paper, 2026 · strength 0.21
  11. G. Aaron Hobbs · 1 shared paper, 2026 · strength 0.21
  12. Michael C. Ostrowski · 1 shared paper, 2026 · strength 0.21
  13. Jonathan M. DeLiberty · 1 shared paper, 2021 · strength 0.09
  14. Kristina Drizyte‐Miller · 1 shared paper, 2021 · strength 0.09
  15. Bjoern Papke · 1 shared paper, 2021 · strength 0.09
  16. Ye S. Lee · 1 shared paper, 2021 · strength 0.09
  17. Emanuel F. Petricoin · 1 shared paper, 2021 · strength 0.09
  18. J. Nathaniel Diehl · 1 shared paper, 2021 · strength 0.09
  19. Calvin Jay Kuo · 1 shared paper, 2021 · strength 0.09
  20. Mariaelena Pierobon · 1 shared paper, 2021 · strength 0.09
  21. Kirsten L. Bryant · 1 shared paper, 2021 · strength 0.09
  22. Adrienne D. Cox · 1 shared paper, 2021 · strength 0.09
  23. Jennifer E. Klomp · 1 shared paper, 2021 · strength 0.09
  24. Clint A. Stalnecker · 1 shared paper, 2021 · strength 0.09
  25. Andrew M. Waters · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.